The importance of histologic grade in long-term prognosis of breast cancer: a study of 1,010 patients, uniformly treated at the Institut Gustave-Roussy.

In a study of 1,010 patients with solitary, unilateral, nonmetastatic breast cancer, the histologic grade, assessed by a multifactorial analysis (Cox model) to study its significance with other prognostic factors, was found to be an important, independent factor. For 612 operable patients, two laboratory characteristics, the number of histologically positive nodes and the histologic grade, were the most valuable predictors. These two factors alone form a predictive index that may be an excellent and simple guide for the clinical decision of subsequent therapy. For 398 patients with inoperable breast cancer (ie, tumor greater than or equal to 7 cm, N2-3, inflammatory, skin fixation, and clinically rapidly growing forms), the histologic grade (performed on drill or cutting needle biopsy) was again a most important (and with inflammatory forms the most important) predictor of prognosis in these patients. Our data support that performing our modified histoprognostic grading of Scarff and Bloom is simple, reproducible, incurs no additional cost, may be carried out in the simplest histology laboratory, and finally, defines an important risk factor in all patients. It should be routine for all breast cancer specimens. Furthermore, studies of adjuvant therapy should stratify patients for this variable.

[1]  M. Tubiana,et al.  Kinetic parameters and the course of the disease in breast cancer , 1981, Cancer.

[2]  D. Cox Regression Models and Life-Tables , 1972 .

[3]  T. Powles,et al.  Prognostic significance of micrometastases in bone marrow in patients with primary breast cancer. , 1986, NCI monographs : a publication of the National Cancer Institute.

[4]  R. Blamey,et al.  Relationship between oestrogen-receptor content and histological grade in human primary breast tumours. , 1978, British Journal of Cancer.

[5]  H. Thaler,et al.  Prognostic significance of tumor emboli in intramammary lymphatics in patients with mammary carcinoma , 1977, The American journal of surgical pathology.

[6]  R. Blamey,et al.  A prognostic index in primary breast cancer. , 1982, British Journal of Cancer.

[7]  B. Fisher,et al.  Pathologic findings from the national surgical adjuvant project for breast cancers (protocol no. 4) X. Discriminants for tenth year treatment failure , 1984, Cancer.

[8]  M Brunet,et al.  Relationship of presence of progesterone receptors to prognosis in early breast cancer. , 1980, Cancer research.

[9]  T. Bauer,et al.  Partial mastectomy: pathologic findings and prognosis. , 1986, Human pathology.

[10]  C. Sutherland,et al.  Long‐term survival and prognostic factors in patients with regional breast cancer (skin, muscle, and/or chest wall attachment) , 1985, Cancer.

[11]  R. Holland,et al.  Mammary carcinoma with osteoclast‐like giant cells: Additional observations on six cases , 1984, Cancer.

[12]  W. W. Richardson Medullary Carcinoma of the Breast , 1956, British Journal of Cancer.

[13]  A. Llombart‐Bosch,et al.  A statistical approach to an individualized prognostic index (IPI) for breast cancer survivability , 1983, Cancer.

[14]  A. Chitale,et al.  Assessment of significance of proportions of intraductal and infiltrating tumor growth in ductal carcinoma of the breast , 1973, Cancer.

[15]  P. Rosen,et al.  Medullary carcinoma of the breast. A clinicopathologic study with 10 year follow‐up , 1977, Cancer.

[16]  E. J. Gregory,et al.  Estrogen receptor as an independent prognostic factor for early recurrence in breast cancer. , 1977, Cancer research.

[17]  J. Coindre,et al.  Soft‐tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system , 1984, International journal of cancer.

[18]  O. Ljungberg,et al.  Atlas of Breast Pathology , 1985 .

[19]  H. Bloom,et al.  Histological Grading and Prognosis in Breast Cancer , 1957, British Journal of Cancer.

[20]  I D Bross,et al.  Cancer of the breast: Size of neoplasm and prognosis , 1969, Cancer.

[21]  M. Ashworth,et al.  Endocrine variant of ductal carcinoma in situ of breast: ultrastructural and light microscopical study. , 1986, Journal of clinical pathology.

[22]  S. Friedman,et al.  Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  M. Tubiana,et al.  The long‐term prognostic significance of the thymidine labelling index in breast cancer , 1984, International journal of cancer.

[24]  J. Coindre,et al.  Reproducibility of a histopathologic grading system for adult soft tissue sarcoma , 1986, Cancer.

[25]  S. Hellman,et al.  Are prognostic factors for local control of breast cancer treated by primary radiotherapy significant for patients treated by mastectomy? , 1986, Cancer.

[26]  R. Gelber,et al.  Prognostic significance of tumor grade in clinical trials of adjuvant therapy for breast cancer with axillary lymph node metastasis , 1986, Cancer.

[27]  J. Coindre,et al.  Micrometastases to axillary lymph nodes from carcinoma of breast: detection by immunohistochemistry and prognostic significance. , 1987, British Journal of Cancer.

[28]  V. Devita,et al.  Cancer : Principles and Practice of Oncology , 1982 .

[29]  P. Saigo,et al.  Predictors of recurrence in stage I (T1N0M0) breast carcinoma. , 1981, Annals of surgery.

[30]  R. Blamey,et al.  The relationship of oestradiol receptor (ER) and histological tumour differentiation with prognosis in human primary breast carcinoma. , 1980, European journal of cancer.

[31]  C. Redmond,et al.  Ten-year results from the National Surgical Adjuvant Breast and Bowel Project (NSABP) clinical trial evaluating the use of L-phenylalanine mustard (L-PAM) in the management of primary breast cancer. , 1986, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  B. Asselain,et al.  Prognostic value of estrogen and progesterone receptors in operable breast cancer: Results of a univariate and multivariate analysis , 1988, Cancer.

[33]  J. Haybittle,et al.  The cancer research campaign (King's/Cambridge trial for early breast cancer: clinico-pathological aspects. , 1982, British Journal of Cancer.